CN103154024A - 新型n末端修饰的胰岛素衍生物 - Google Patents

新型n末端修饰的胰岛素衍生物 Download PDF

Info

Publication number
CN103154024A
CN103154024A CN2011800496891A CN201180049689A CN103154024A CN 103154024 A CN103154024 A CN 103154024A CN 2011800496891 A CN2011800496891 A CN 2011800496891A CN 201180049689 A CN201180049689 A CN 201180049689A CN 103154024 A CN103154024 A CN 103154024A
Authority
CN
China
Prior art keywords
insulin
human insulin
desb30 human
gglu
terminal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2011800496891A
Other languages
English (en)
Chinese (zh)
Inventor
P.马德森
P.巴尔施密特
S.哈夫伦
T.赫格-延森
T.B.克杰尔德森
C.H.菲恩博
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of CN103154024A publication Critical patent/CN103154024A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
CN2011800496891A 2010-10-15 2011-10-14 新型n末端修饰的胰岛素衍生物 Pending CN103154024A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP10187706 2010-10-15
EP10187706.6 2010-10-15
US39409010P 2010-10-18 2010-10-18
US61/394,090 2010-10-18
PCT/EP2011/068019 WO2012049307A2 (en) 2010-10-15 2011-10-14 Novel n-terminally modified insulin derivatives

Publications (1)

Publication Number Publication Date
CN103154024A true CN103154024A (zh) 2013-06-12

Family

ID=43638785

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011800496891A Pending CN103154024A (zh) 2010-10-15 2011-10-14 新型n末端修饰的胰岛素衍生物

Country Status (5)

Country Link
US (1) US20140315797A1 (enExample)
EP (1) EP2627670A2 (enExample)
JP (1) JP2013540771A (enExample)
CN (1) CN103154024A (enExample)
WO (1) WO2012049307A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113646329A (zh) * 2019-03-29 2021-11-12 诺和诺德股份有限公司 葡萄糖敏感性胰岛素衍生物

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010009850A (es) 2008-03-18 2010-09-30 Novo Nordisk As Analogos de insulina acilados y etabilizados contra proteasas.
KR20150002777A (ko) 2012-04-11 2015-01-07 노보 노르디스크 에이/에스 인슐린 제제
SG10201809457YA (en) * 2014-11-21 2018-11-29 Merck Sharp & Dohme Insulin receptor partial agonists
WO2017032795A1 (en) * 2015-08-25 2017-03-02 Novo Nordisk A/S Novel insulin derivatives and the medical uses hereof
CA2996455A1 (en) 2015-08-25 2017-03-02 Novo Nordisk A/S Novel insulin derivatives and the medical uses hereof
EP3341402A1 (en) * 2015-08-25 2018-07-04 Novo Nordisk A/S Novel insulin derivatives and the medical uses hereof
EP3458032A4 (en) 2016-05-16 2019-12-25 The Board of Regents of The University of Texas System CATIONIC SULFONAMIDE AMINOLIPIDS AND AMPHIPHILE ZWITTERIONIC AMINOLIPIDS
MA49116A (fr) 2016-12-16 2020-03-25 Novo Nordisk As Compositions pharmaceutiques contenant de l'insuline
PE20211264A1 (es) 2017-08-17 2021-07-15 Novo Nordisk As Analogos de insulina acilados novedosos y usos de estos
SG11202106168VA (en) 2018-12-11 2021-07-29 Sanofi Sa Insulin analogs having reduced insulin receptor binding affinity
FI4073097T3 (fi) 2019-12-11 2024-08-13 Novo Nordisk As Uusia insuliinianalogeja ja niiden käyttötapoja

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008145721A2 (en) * 2007-06-01 2008-12-04 Novo Nordisk A/S N-terminal modification of polypeptides for protection against degradation by aminopeptidases
WO2009022005A1 (en) * 2007-08-15 2009-02-19 Novo Nordisk A/S Insulin analogues with an acyl and alkylene glycol moiety

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI0792290T1 (en) * 1993-09-17 2001-12-31 Novo Nordisk As Acylated insulin
KR101159559B1 (ko) 2003-08-05 2012-06-26 노보 노르디스크 에이/에스 신규의 인슐린 유도체
JP5410020B2 (ja) * 2005-02-02 2014-02-05 ノヴォ ノルディスク アー／エス インスリン誘導体
EP1888118B1 (en) 2005-05-25 2016-08-17 Novo Nordisk A/S Polypeptide formulations stabilized with ethylenediamine
EP2404934A1 (en) 2006-09-22 2012-01-11 Novo Nordisk A/S Protease resistant insulin analogues
EP2164466A1 (en) * 2007-06-01 2010-03-24 Novo Nordisk A/S Spontaneously dispersible preconcentrates including a peptide drug in a solid or semisolid carrier
MX2010009850A (es) 2008-03-18 2010-09-30 Novo Nordisk As Analogos de insulina acilados y etabilizados contra proteasas.
CN106317164A (zh) * 2008-09-12 2017-01-11 诺沃—诺迪斯克有限公司 酰化肽或蛋白的方法
EP2344200A2 (en) 2008-09-19 2011-07-20 Nektar Therapeutics Modified therapeutics peptides, methods of their preparation and use
EP2370059A1 (en) * 2008-11-28 2011-10-05 Novo Nordisk A/S Pharmaceutical compositions suitable for oral administration of derivatized insulin peptides
CN102753150A (zh) 2010-01-12 2012-10-24 诺沃—诺迪斯克有限公司 用于口服给予胰岛素肽的药物组合物

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008145721A2 (en) * 2007-06-01 2008-12-04 Novo Nordisk A/S N-terminal modification of polypeptides for protection against degradation by aminopeptidases
WO2009022005A1 (en) * 2007-08-15 2009-02-19 Novo Nordisk A/S Insulin analogues with an acyl and alkylene glycol moiety

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
WAYNE D.KOHN等: "pI-shifted insulin analogs with extended in vivo time action and favorable receptor selectivity", 《PEPTIDES》 *
黄涛: "化学修饰胰岛素的制备、表征和生物活性", 《中国博士学位论文全文数据库工程科技I辑》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113646329A (zh) * 2019-03-29 2021-11-12 诺和诺德股份有限公司 葡萄糖敏感性胰岛素衍生物
CN113646329B (zh) * 2019-03-29 2025-12-09 诺和诺德股份有限公司 葡萄糖敏感性胰岛素衍生物

Also Published As

Publication number Publication date
EP2627670A2 (en) 2013-08-21
WO2012049307A2 (en) 2012-04-19
WO2012049307A3 (en) 2012-06-14
US20140315797A1 (en) 2014-10-23
JP2013540771A (ja) 2013-11-07

Similar Documents

Publication Publication Date Title
CN103154024A (zh) 新型n末端修饰的胰岛素衍生物
ES2611007T3 (es) Análogos de insulina acilada, estabilizados frente a proteasas
ES2672770T3 (es) Derivados del péptido-1 similar al glucagón y su uso farmacéutico
JP5931857B2 (ja) 追加のジスルフィド結合を含有するインスリン誘導体
JP2020169197A (ja) 新規のアミリン及びカルシトニン受容体アゴニスト
AU2014333979B2 (en) Novel derivative of an insulin analogue
AU2006224537A1 (en) Extended GLP-1 compounds
ZA200707261B (en) Acylated GLP-1 compounds
JP2010538049A (ja) 切断型ｇｌｐ−１誘導体及びその治療的使用
JP2011520847A (ja) 遅効型ｙ２及び／又はｙ４レセプターアゴニスト
CN104364262A (zh) N末端修饰的胰岛素衍生物
BR112012029248B1 (pt) Análogo de glp-1 de fórmula i ou a sua composição, análogo de glp-1 de fórmula viii ou um sal farmaceuticamente aceitável ou a composição do mesmo, composição farmacêutica e uso de um composto
JP6013330B2 (ja) 追加のジスルフィド結合を含有するヒトインスリン
TW201307381A (zh) 新穎的ｎ－端經修飾胰島素衍生物
AU2013205270B2 (en) Protease stabilized, acylated insulin analogues
EA050089B1 (ru) Полипептиды и варианты их применения

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20130612